EGFR and cancer: In this project, the effect of each of these factors on breast cancer cells was investigated, and it was shown that anti-EGFR nanobody and death receptor ligand (DRL) alone have little apoptotic effect on cancer cells, but when these two molecules are joined together, they can effectively induce apoptosis in TNBC cells.